Skip to content

Clinical trials

Phase 3 Irritable Bowel Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Irritable Bowel Syndrome Phase: Phase 3 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20091
20101
20123
20142
20162
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated4
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Furiex Pharmaceuticals, Inc2
GlaxoSmithKline2
Menarini Group2
AbbVie1
Bausch Health Americas, Inc.1
Celgene1
Forest Laboratories1
Mood and Anxiety Research, Inc1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Irritable Bowel Syndrome16
Diarrhea4
Abdominal Pain3
Intestinal Diseases3
Colonic Diseases, Functional2
Constipation2
Anxiety Disorders1
Borderline Personality Disorder1
Colonic Diseases1
Colonic Pseudo-Obstruction1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.